Dr Valerin discusses the role of liposomal irinotecan in pancreatic cancer management and factors influencing the decision to use this agent in practice.
Jennifer B. Valerin, MD, PhD
Advertisement
Jennifer B. Valerin, MD, PhD, is an assistant professor in the Divisions of Hematology and Oncology and Medicine at the University of California, Irvine School of Medicine.
Articles by Jennifer B. Valerin, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
ASCO Guideline Update Broadens First-Line Treatment Options for HER2+ Gastroesophageal Cancer
2
ASCO Issues First Guideline on ctDNA Testing in Solid Tumors and Lymphoma
3
CAR T-Cell Therapy Continues to Make Its Case in Early Relapsed Myeloma
4
European Commission Approves Teclistamab Plus Daratumumab for R/R Myeloma
5